A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm. The post New state-of-the-art test identifies ...
With kidney diseases rising steadily across India, Manipal specialists have stressed the need for early screening, lifestyle awareness and greater public understanding of kidney donation. Addressing a ...
The 2026 European Association of Urology (EAU) annual meeting featured an advancements in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr. Giulio ...
Bladder Pain Syndrome is believed to arise from bladder wall hypersensitivity and disruption of its protective lining, ...
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
The March session of the University of Iowa’s AI Lightning Talks, themed “AI in Research: Inside Faculty Workflows,” featured staff and faculty who have been implementing artificial intelligence into ...
Johnson & Johnson today announced results from an open-label, multicenter Phase 1 study evaluating an investigational intravesical drug-releasing system with erdafitinib (Erda-iDRS) in patients with ...
(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr ...
Ardian, Charterhouse, CVC and L Catterton are among the PE firms investing in different areas of the women's healthcare market.
Urologists at Vanderbilt Health are enrolling men with stress urinary incontinence (SUI) in a clinical trial named SOPHIA2 to assess the safety and efficacy of the UroActive implant, following an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results